Psychedelia.dk

Kimball"


Søgeresultat 14
Fra:usurper (joust@camelot.com)
Emne:The Other Drug War (Politics In Healing)
Dette er den eneste artikel i denne tråd
View: Original Format
Nyhedsgruppe:sci.med.diseases.cancer
Dato:2001-07-15 07:10:07 PST


The Other Drug War

by Daniel Haley


Most people know about the U.S. government's "war
on drugs," so the fact that federal agents arrested
James T. Kimball last fall for supplying drugs
doesn't sound remarkable. However, Mr. Kimball was
not selling any type of illegal "street" drug. His
crime was distributing a botanical product that has
been proven effective in treating symptoms of
Parkinson's disease. This bust was an example of
another kind of drug war that the government is
waging: a war on nontoxic substances that compete
with products of the pharmaceutical industry.

Make no mistake: this is a classic turf war, with
government agencies protecting the hugely profitable
prescription drug trade.


As a member of the New York State Legislature
from 1970 to 1976, I became intimately
acquainted with the political patterns -- the
harassment of American citizens and the
suppression of information -- that characterize
this war. My experiences led me to record ten
examples of them in my book, Politics in Healing:
The Suppression and Manipulation of American
Medicine.


AN EVOLVING BATTLEFIELD
An essential way in which alternative medicine
differs from conventional medicine is the latter's
reliance on invasive procedures and toxic drugs
to suppress symptoms, while alternative medicine
treats the patient as a whole and goes to the
greatest lengths to "first do no harm." Those
attracted to alternative medicine have been voting
with their pocketbooks to show their preference
for gentler approaches. According to a recent
study by Harvard University, last year,
Americans made an estimated 600 million office
visits to practitioners of alternative medicine and
spent $30 billion on treatments. For "official
medicine" to maintain its current sovereignty,
therefore, it must suppress nontoxic medical
techniques and treatments. It does so by
spreading misinformation; by sabotaging clinical
trials or ignoring the positive results; by
preventing patient reimbursement for alternative
treatments; and/or by outlawing the practice and
use of nontoxic techniques or even health claims
for nutritional supplements. Most brutal,
however, is the persecution of alternative
physicians, researchers, product manufacturers
and distributors through the legal system --
whether or not any laws have been broken, and
when no one has been harmed.

What is "official medicine?" It is the American
Medical Association (AMA), major hospitals and
medical schools, medical philanthropic and
research institutions, and the FDA -- all of whom
are dominated by the pharmaceutical industry,
which funds most of the medical research, buys
the most advertising and makes the largest
campaign contributions and lobbying efforts. In
their May 19, 2001 issue, the British medical
journal The Lancet published an editorial in
which it accused the FDA of having become a
"servant of the drug industry."

As for James Kimball, the FDA arrested and
prosecuted him for distributing liquid deprenyl,
calling it an unapproved drug and charging him
with misbranding and fraud. In fact, many of the
charges were contradictory, aiming to catch him
in the net of definitions of "nutritional
supplements" and "unapproved drugs" with all the
conflicting restrictions that go with each.

Parkinson's Disease is correlated with a
deficiency of the neurotransmitter dopamine,
manifesting in decreased mobility, energy and
cognitive function. Conventional treatment has
used a precursor of dopamine, L-dopa, to raise
dopamine levels.

However, some complex conditions in the brain
that might cause a dopamine deficiency in the first
place prevent such a simplistic solution from
working. Dopamine is degraded by an enzyme
called monoamine oxidase type B. Liquid
deprenyl citrate (LDC), also known as selegiline,
works by specifically inhibiting this enzyme from
destroying the brain's dopamine. Research by
C.W. Olanow, M.D., Chairman of the
Department of Neurology at the Mt. Sinai School
of Medicine in New York, has shown that liquid
deprenyl had favorable results in Parkinson's
disease, compared with L-dopa, which is known
to have adverse side effects. In fact, some
patients found that liquid deprenyl was the only
thing that, in the words of many, "gave them back
their lives."

LDC's components are extracted from natural
sources and therefore the compound is classified
as a botanical nutritional supplement, as defined
by the Dietary Supplement and Health Education
Act (DSHEA). But the problem wasn't that the
FDA had reports of adverse effects of LDC. In
fact, during the trial, the government could not
produce a single witness to testify that any harm
was done to even one of the thousands of people
who used liquid deprenyl.

The real problem was its competition with other
patented drugs, including Eldepryl (selegi-line
hydrochloride), distributed in the U.S. by
Somerset Pharmaceuticals, which is jointly
owned by Mylan Laboratories and Watson
Pharmaceuticals. According to Kimball, testing of
Eldepryl in Switzerland in the late 1980s, prior to
FDA approval, revealed impurities (that were
later identified as methamphetamines and other
neurotoxins) which resulted in serious adverse
side effects. Not so for liquid deprenyl, with its
very high standards of purity. Studies by the
Parkinson's Disease Research Group in Britain in
the 1990s also showed adverse and sometimes
fatal ,side effects when combining selegiline
hydrochloride with L-Dopa in treating
Parkinson's. This had nothing to do with
Kimball's liquid deprenyl citrate product, which
was molecularly unique. Nevertheless, during the
trial the FDA refused to distinguish Kimball's
product from these others. He was found guilty
and sentenced to 13 years. He is presently
incarcerated while his case is being appealed.

Documents available for viewing on Kimball's
website (http://www.liquid-deprenyl.com) prove that
the coordinated, multi-jurisdictional task force
that led to his arrest was instigated by the maker
of Eldepryl: Somerset Pharmaceuticals. Eldepryl
is still on the market.

For Kimball, and for all the families counting on
this remedy to bring some normalcy back to their
lives, the raid, trial and verdict were devastating.
What is especially disturbing is that this is not an
isolated incident. In fact, there is a long history of
interference by the federal government in the
development, distribution and use of nontoxic,
alternative remedies.


SCARY SCENARIOS
Nowhere is the suppression of nontoxic therapies
a sadder commentary on the medical system than
in treating cancer. Those facing this frightening
disease must also face toxic radiation and
chemotherapy -- despite the fact that there are
nontoxic options for which there is anecdotal
evidence that thousands were helped and no one
was hurt. No one, that is, except those who
became scapegoats of a corrupt system, as
revealed in these stories.

THE HOXSEY STORY
In 1840, the Hoxsey family observed that a horse
which had been afflicted with cancer had been
cured after eating certain herbs in its pasture in
Illinois. Those herbs became the basis for the
Hoxsey tonic and salves. They were kept for
family use until the 20th century, when Harry
Hoxsey used them at a series of clinics, the final
one being in downtown Dallas. In the 1920s,
Hoxsey refused to sell his formulas to a powerful
AMA doctor. Shortly afterward, Dr. Morris
Fishbein, editor of the Journal of the American
Medical Association (JAMA) and de facto head
of the AMA, began to denounce Hoxsey as a
quack in his JAMA editorials. The battle reached
its zenith when Hoxsey succeeded in suing
Fishbein for libel, forcing him to admit under oath
that he had never practiced medicine one day in
his life; in other words, the head of the AMA was
a bogus doctor.

During the trial, Fishbein granted that the Hoxsey
treatment was effective for external cancers, such
as the skin cancers melanoma and basal cell
carcinoma. In 1962, the Hoxsey Clinic was finally
driven out of the U.S. by the AMA and the
Texas Medical Board, and moved to Tijuana,
Mexico, where it remains as the Centro
Biomedico. With consistent success, it needs only
word of mouth to maintain a constant flow of
patients.

Although the Hoxsey herbs were once
denounced as worthless, all have recently been
shown to have anti-cancer activity. For example,
one ingredient, an arsenic compound, has since
been shown to reverse a rare form of leukemia
called APL (acute promyelocytic leukemia) when
a version of a Chinese formulation was tested. It
has since been approved by the FDA and is
being used at Memorial Sloan-Kettering in New
York, Dana-Farber Cancer Institute in Boston
and other "official" American cancer centers.

THE KOCH STORY
Just how far we have regressed in treating cancer
becomes apparent when we review the story of
Dr. William F. Koch (pronounced "Coke") of
Detroit, who was curing cancer with one shot in
the 1930s and 40s. Koch had theorized that
cancer formed as a result of a metabolic defect
brought on by a toxin or injury and related to an
inability to burn off such toxins. His anti-toxin,
glyoxylide, made use of an oxidizing catalyst to
burn off toxins that might otherwise become
cancerous. This writer personally knows one
such former patient. Now 50 and quite healthy,
she had been diagnosed -- at the tender age of
three months -- with terminal liver cancer. It
took just one shot of Dr, Koch's glyoxylide to
cause the tumor to disappear in six months.

The JAMA denounced Koch as a quack after he
refused to sell his protocol to the AMA. At the
instigation of the AMA, the FDA put him on trial
in 1942 and 1946. They did not succeed in
getting a conviction, but neither could Dr. Koch
secure an acquittal: in the atmosphere of the U.S.
struggle against the Nazis, some jurors could not
conceive that their government was lying. When
the FDA finally dismissed the indictment in 1948,
Dr. Koch lost little time moving to Brazil before
the FDA could trump up another indictment. He
never revealed his manufacturing process. Dr.
Koch's one-shot cancer therapy died with him.
Today researchers have shown the value of many
oxygen-yielding protocols (such as hydrogen
peroxide and ozone therapy) for treating various
disease processes.

THE RIFE STORY
In the 1920s and 30s in San Diego, Royal Rife
built a light microscope capable of seeing viruses
in their live state. (An electron microscope only
sees microbes after they are dead.) Rife found
microbes that he hypothesized caused cancer,
and, indeed, found that when he injected the
microorganisms into mice, the mice developed
cancer. Rife noticed that the microorganisms,
which he called Bacillus X, or the BX virus, were
a purplish-red color, corresponding to an
electromagnetic frequency. He hypothesized that
they could be killed by being exposed to another
frequency that would resonate with the vibratory
rate of the microbe. Rife then spent years
searching for the proper frequencies and at last
he found them. Rife began human trials,
monitored by such medical stalwarts as Dr.
Arthur Kendall, Director of Medical Research at
Northwestern University; Dr. Milbank Johnson,
Medical Director of the Pacific Mutual Life
insurance Co. and former President of the Los
Angeles Medical Association; and Dr. Alvin
Foord, Head of Pathology at Pasadena Hospital.
Rife broadcasted these frequencies to terminally
ill cancer patients, in five-minute exposures every
third day. After six weeks of exposures to these
frequencies, 15 of 16 patient's cancers went into
remission.

Rife's fame grew and he was brought to the
attention of the same Morris Fishbein of the
AMA. Soon, corporate interests attempted to
buy the Rife technology, and when Rife refused
to divulge his proprietary technology, trouble
started. First there were lawsuits as to who
actually owned what. Then, in 1939, the San
Diego Medical Society warned that any doctors
who used Rife's instruments would lose their
licenses. Rife's company had to shut down. The
instruments that survived had parts stolen or
eventually broke down. Rife died in 1971.

Today there are techniques, usually called
bioresonance therapies, similar to Rife's work,
that are being used medically -- mostly outside
the U.S. But the Rife microscope and the exact
frequencies he developed are lost.

KREBIOZEN
In the 1950s, Dr. Andrew Ivy, then Vice
President of the University of Illinois, and one of
the most respected scientists in the world, came
upon Krebiozen (pronounced "kreb-I-o-zen"), an
important, nontoxic cancer treatment attributed to
Yugoslavian doctor, Stefan Durovic. Krebiozen
was made in response to animal tumors believed
to be caused by a fungus. After injecting the same
fungus into a horse to create an immune
response, the researchers extracted and diluted
the blood product, which quickly healed sick
animals. In human studies, it rapidly eliminated
pain and dissolved tumors. The substance
immediately attracted the attention of prominent
figures in the medical world. Some powerful
doctors, however, didn't just want to use
Krebiozen, they were determined to own and
control it.

Sworn testimony presented to a special
investigating committee of the Illinois Legislature
in 1952 detailed a scheme by the AMA
treasurer, J. J. Moore, to secure the distribution
rights for Krebiozen. Failing that, Moore intended
to destroy it, as well as the career of its chief
proponent, Dr. Andrew Ivy. Moore did not
secure distribution rights for Krebiozen, but did
manage to get Dr. Ivy fired from his University of
Illinois post, and from other positions as well.
Krebiozen was later denounced by the National
Cancer Institute (NCI) and outlawed by the
FDA.

Hundreds of cancer patients -- kept alive by
Krebiozen -- demonstrated, demanding access
to the drug, lest they die. They were ignored, and
they died.

The FDA announced that its scientists had found
that Krebiozen was only creatine, an amino acid.
But Senator Paul Douglas of Illinois revealed,
during testimony in the Senate, that his own
independent researchers had discovered that
FDA scientists had falsified data: moving a graph
by 8% to make it appear that Krebiozen and
creatine were identical. Subjected to
cross-examination under oath in a trial a few
years later, the FDA scientists admitted their
deceit. But by then, Krebiozen had disappeared.

U.S. Department of Justice investigator Benedict
Fitzgerald confirmed in his report to a Senate
committee that the "alleged machinations of Dr.
J.J. Moore, Treasurer of the AMA, could involve
the AMA and others in an interstate conspiracy
of alarming proportions."


A THING OF THE PAST?
Is this kind of harassment a thing of the past?
Hardly! It is happening right now. Within the past
two years, readers of Alternative Medicine have
learned about the ongoing persecution of two
pioneer cancer researchers: Dr. Stanislaw
Burzynski, for his antineoplastin therapy
(Alternative Medicine, issue 35, May, 2000),
and Dr. Joseph Gold, for his work with hydrazine
sulfate ("If it were any good, my doctor would tell
me about it..." Alternative Medicine, issue 37,
September, 2000).

A recent case involves amygdalin, or laetrile,
extracted from apricot pits. Discrediting and
outlawing laetrile was the FDA's big crusade 20
to 25 years ago. A pretty thorough job was done
of equating laetrile with quackery in the minds of
many Americans. In the minds of many others,
however, laetrile was a useful and nontoxic
cancer therapy, and if it didn't help you, at least it
didn't sicken you and make your hair fall out. A
number of states legalized laetrile at that time.

In 1990, a 19-year-old boy named Jason Vale in
Queens, New York, developed a tumor on his
kidney. The tumor went away under
chemotherapy, returned the next year and went
away once more with chemo. When the cancer
returned a third time when he was 25, he decided
to try something else -- apricot pits, a source of
laetrile. They worked: The tumor went away and
stayed away.

With the zeal of an evangelist, Jason set up a
website to tell others how he'd conquered cancer
with apricot pits, and also started a business to
supply them to interested parties. He included a
picture of himself, a husky, healthy young man of
30, now a champion arm wrestler. As clients
reported success, Jason added their stories to his
website.

In 1997, however, he was notified by America
Online (AOL) that he was in violation of the law
for sending unsolicited e-mails -- "spamming."
This brought Vale to the attention of the FDA,
which raided his home in November, 1997. Vale
watched FDA inspectors collect samples of his
products and acknowledged full responsibility for
marketing them.

The FDA also ordered products through Vale's
website and in October, 1998, sent Vale a letter
warning him that his laetrile products were
unapproved new drags, and that he could no
longer make health claims for them or sell them.
Vale's lawyer responded that the laetrile products
were food for special dietary use by virtue of
their ingredients, and Vale continued to sell them.
In February, 1999, the FDA again raided Vale's
home; again Vale insisted that his products were
not drugs and he would not voluntarily shut
down. Finally, in November, 1999, the FDA filed
a complaint for a permanent injunction against
Vale for selling unapproved new drugs. In April,
2000, a U.S. District Court granted the motion,
and Vale was ordered never again to sell laetrile
products.

Another case came to my attention when my
book was published last year. I was informed
that the phone number in the Appendix for Donna
Schuster, a longtime supplier of hydrazine sulfate
(HS), was disconnected. I learned that she was
out of business. The FDA had closed down her
supplier, Ken Michaelis, indicting him on 16
counts, including defrauding the FDA by failing to
register as a drug manufacturer.

This turns out to be a game of semantics. Ken
was not manufacturing anything, but simply
repackaging both HS and amygdalin in smaller
batches for distributors. The FDA informed him
that it considered repackaging to be the same as
manufacturing. His brother told me that Ken is
under an FDA "gag order" not to talk about the
details of his case -- and not to talk to his
customers. (Editor's Note: The trial is scheduled
to start as we go to press. For more details, go to
the website: http://www.holisticalternatives.net and
press "congressional correspondence.")


MEDICAL TRUTH OR POWER PLAY?
The persecutions go on and on. Last year the
FDA arrested Allen Hoffman for distributing a
concentrated form of aloe vera, one of the oldest
herbs known to man, used by Julius Caesar and
Alexander the Great's armies for battle wounds.

DMSO was another persecuted drug. Dr.
Stanley Jacob, its chief researcher, found that
when antibiotics that were no longer effective
were mixed with DMSO, this remarkable
substance rendered bacteria vulnerable to them
once again. Used soon after a stroke, either
intravenously or orally, DMSO could dissolve the
stroke. Hailed by The New York Times as the
wonder drug of the 1960s, it is now all but
forgotten.

Similar stories abound for immune-enhancing
products and other nontoxic therapies. These
substances are threats to patented drugs because
they are cheap, effective and don't have adverse
side effects. In many instances, members of the
orthodox medical community knew that these
therapies were effective, and had attempted to
take over the protocol. After being rebuffed, they
resorted to persecution.

Moreover, in January, 1999, Business Week
reported the fourth leading cause of
hospitalizations: damage from FDA-approved
drugs, affecting 2.2 million people a year at a cost
of $5 billion. Americans are dying, one every
three to five minutes, from the effects of
FDA-approved pharmaceutical drugs, used as
directed! In the face of such FDA dereliction of
duty, against such a dismal background, who
orders these raids?

Also, in 1999, the Journal of the American
Medical Association reported that the fourth
leading cause of death in the U.S. was side
effects from properly administered,
FDA-approved drugs. Congress did pass an
"FDA Reform Bill," but it did nothing to address
this issue. With huge contributions from the
pharmaceutical companies, not one congressmen
was indelicate enough to mention the statistic.

For this reporter, a New York State
assemblyman in the 1970s, there is a solution to
the drug problem (and I don't mean illegal street
drugs, which kill only 10% as many people as
legal drugs kill). The solution is simple:
competition. Get the government out of the
regulation of anything nontoxic.

In a free market, where non-toxic therapies can
openly compete with toxic therapies, and
information is not suppressed, consumers will
make informed choices. This is exactly what the
pharmaceutical companies don't want. Dancing to
their tune, the FDA ferociously keeps off the
market effective, nontoxic therapies that might
provide formidable competition for patented, and
often toxic, pharmaceutical drugs.

By keeping these therapies off the market, the
FDA is not protecting the public from harm. It is
protecting the pharmaceutical companies from
effective competition. With an average of 65% to
75% of FDA employees working for drug
companies upon their retirement, that's not
surprising. Lancet editor Richard Horton wrote,
"The FDA is not only compromised because it
receives so much funding from industry but
because it comes under incredible Congressional
pressure to be favourable to industry. That has
led to deaths."

Having freedom of medical choice can be a
matter of life or death. Hundreds of thousands of
people suffer and die needlessly every year.
Control of medicine has historically been
associated with corrupt or totalitarian regimes.
It's time to separate the politics of wealth and
power from the healing arts.

To take action, visit the consumer activist website
Citizens for Health (http://www.citizens.org) for
updates on current legislation, such as the Health
Freedom of Choice Act and the Access to
Medical Treatment Act; information on how to
contact key legislators and regulatory agency
officials; and links to other activist organizations.
Get involved. Sign petitions or write to your
legislators.

Your basic freedoms are at stake -- and quite
possibly your life, or the life of someone you love.


* * * *

Politics In Healing

"Daniel Haley has written a
very important book about
the medical profession,
detailing the struggles
between good and evil
as no one ever has before.
Incredible as these stories
are they are true!"

-- Julian Whitaker, M.D.

* * * *

To order call
800-898-0639
or visit:

politicsinhealing.com



COPYRIGHT ALTERNATIVE MEDICINE
MAGAZINE · SEPTEMBER 2001 · ISSUE 43


-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=

Hooked on cancer drugs

The profitable future of
conventional cancer therapy?

The newest direction in cancer research seems
designed to turn the cancer patient into a lifetime
customer for the pharmaceutical companies.
According to New Medicine Oncology KnowledgeBASE,
there are over 500 anti-cancer drugs in development,
targeting a variety of markers associated with cancer.
These drugs seem to redefine cancer from a short-term
deadly disease to a long-term chronic one, with
patients relying on a lifetime of medication to stay
alive. The drugs are designed not to replace but
to enhance the effectiveness of cytotoxic
chemotherapy and/or radiation, and to provide a
long-term treatment option to prevent
recurrences. Anti-cancer mechanisms intended to
be supported by these new drugs include inhibiting
tumor blood supply (anti-angiogenesis), programmed
cell death (apoptosis), and tumor-associated
antigen targeting. The pharmaceutical industry
claims that this represents a fundamentally new
approach to the treatment of cancer.

Editor's note: Interestingly,
anti-angiogenesis, enhanced apoptosis and
antigen targeting are exactly the mechanisms
used by alternative cancer doctors to
successfully reverse cancer in many patients
and provide lasting remission. The difference
is that they generally use natural,
non-patentable substances with minimal or no
negative side effects, and only in concert with
nutritional and detoxification protocols.



COPYRIGHT ALTERNATIVE MEDICINE
MAGAZINE · SEPTEMBER 2001 · ISSUE 43


-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=


Profile of A Cancer Patient

In a study of new cancer patients at the Cancer
Treatment Center of Tulsa, Oklahoma, most patients
smoked or had smoked, did not like to eat green
vegetables, had below normal body temperatures,
rarely exercised to a sweat, ate large proportions
of refined flour products (bread, crackers, cookies,
rolls) had a stressful event in their recent history,
and last but not least, drank soda pop, colas,
coffee, bottled juices, and very little water.

-- Wheatgrass, Nature's Finest Medicine (p. 77)

-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=


--------------------------------------------------------------------------------


©2004 Google

http://groups.google.dk/groups?q=%22Jam ... om&rnum=14